Lina Khan, FTC chair (Graeme Jennings/Pool via AP Images)

Pile-on over PBMs con­tin­ues with FTC com­ments and a new bi­par­ti­san Sen­ate bill

More than 500 stake­hold­ers sent com­ments to the FTC on whether the com­mis­sion should look fur­ther in­to phar­ma mid­dle­men, known as PBMs, with many of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.